NHÂN MỘT TRƯỜNG HỢP THUYÊN TẮC PHỔI CÓ RỐI LOẠN HUYẾT ĐỘNG ĐIỀU TRỊ THÀNH CÔNG BẰNG TIÊU SỢI HUYẾT TẠI BỆNH VIỆN ĐẠI HỌC Y DƯỢC THÀNH PHỐ HỒ CHI MINH

Abstract

Pulmonary embolism (PE) is a potentially life- threatening condition requiring urgent management to decrease mortality. PE typically has a poor prognosis with a high mortality rate despite advances in diagnosis and therapy. The clinical signs and symptoms of PE are non-specific and in some cases, PE may be asymptomatic or discovered incidentlly during diagnostic workup for another disease. Treatment options for pulmonary embolism include anticoagulation therapy, thrombolytic therapy, or insertion of an inferior vena cava filter when anticoagulation is contraindicated. The long-term benefits of thrombolytic therapy have made it an increasingly popular option in many institutions In this report, we present a case of PE presenting with

dyspnea and chest pain for one week. The patient was successfully managed with a full dosage of the systemic thrombolytic drug and discharged after 11 days with with no complications.